BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Absmeier RM, Rottenaicher GJ, Svilenov HL, Kazman P, Buchner J. Antibodies gone bad - the molecular mechanism of light chain amyloidosis. FEBS J 2023;290:1398-419. [PMID: 35122394 DOI: 10.1111/febs.16390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sizova DV, Raiker S, Lakheram D, Rao V, Proffitt A, Jmeian Y, Voegtli W, Batonick M. Producing amyloid fibrils in vitro: A tool for studying AL amyloidosis. Biochem Biophys Rep 2023;34:101442. [PMID: 36875796 DOI: 10.1016/j.bbrep.2023.101442] [Reference Citation Analysis]
2 Rottenaicher GJ, Absmeier RM, Meier L, Zacharias M, Buchner J. A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis. Commun Biol 2023;6:209. [PMID: 36823438 DOI: 10.1038/s42003-023-04574-y] [Reference Citation Analysis]
3 Del Pozo-yauner L, Turbat-herrera EA, Pérez-carreón JI, Herrera GA. From the Light Chain Sequence to the Tissue Microenvironment: Contribution of the Mesangial Cells to Glomerular Amyloidosis. Hemato 2022;3:232-267. [DOI: 10.3390/hemato3010019] [Cited by in F6Publishing: 1] [Reference Citation Analysis]